Repaglinide glucose oscillation study in Fukuoka

Trial Profile

Repaglinide glucose oscillation study in Fukuoka

Phase of Trial: Phase II/III

Latest Information Update: 05 Aug 2015

At a glance

  • Drugs Repaglinide (Primary) ; Glimepiride
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms REGO-F
  • Most Recent Events

    • 05 Aug 2015 Planned number of patients changed from 100 to 120, according to University Hospital Medical Information Network - Japan record.
    • 17 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top